Pim kinase-dependent inhibition of c-Myc degradation (Q28592035)

31 January 2017

title

Pim kinase-dependent inhibition of c-Myc degradation (English)

1 reference

Myelocytomatosis oncogene

31 January 2017

main subject

1 reference

Proviral integration site 2

GOA release 2020-03-11

1 reference

Serine/threonine-protein kinase pim-1

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

Y. Zhang

1

1 reference

31 January 2017

Z. Wang

2

1 reference

31 January 2017

X. Li

3

1 reference

31 January 2017

N. S. Magnuson

4

1 reference

31 January 2017

language of work or name

English

0 references

publication date

14 August 2008

1 reference

31 January 2017

1 reference

31 January 2017

volume

27

1 reference

31 January 2017

issue

35

1 reference

31 January 2017

page(s)

4809–4819

1 reference

31 January 2017

cites work

Myc and the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Pim kinase substrate identification and specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Pim family kinases enhance tumor growth of prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Mechanism of transcriptional activation by the Myc oncoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

The great MYC escape in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Oncogene expression in Rauscher murine leukemia virus induced erythroid, myeloid and lymphoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Delineation of prognostic biomarkers in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Characterization of the proto-oncogene pim-1: kinase activity and substrate recognition sequence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

The MAX-interacting transcription factor network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

c-MYC: more than just a matter of life and death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

The Myc oncoprotein as a therapeutic target for human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Transcriptional repression by Myc.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123

Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.123